CYTOKINETICS, INCORPORATED Other Non-Current Liabilities
CYTOKINETICS, INCORPORATED (CYTK) had Other Non-Current Liabilities of $1.61 million as of 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2025-11-05
- 2025-09-30: Other Liabilities, Noncurrent $1.61M.
- 2025-06-30: Other Liabilities, Noncurrent $2.02M.
- 2025-03-31: Other Liabilities, Noncurrent $2.82M.
- 2024-12-31: Other Liabilities, Noncurrent $0.00.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2025-09-30 | $1.61M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.02M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.82M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-05 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-09 |
| 2024-03-31 | $2.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $186.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $408.00K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $625.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $837.00K 10-Q · filed 2023-05-05 |
| 2022-12-31 | $1.04M 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.25M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $1.44M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $3.21M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $4.46M 10-K · filed 2023-03-01 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-25 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-01 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-09 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 |
| 2018-12-31 | $771.00K 10-Q · filed 2019-11-01 |
| 2018-09-30 | $873.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $974.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $1.03M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $1.10M 10-K · filed 2019-03-07 |
| 2017-06-30 | $2.00K 10-Q · filed 2017-08-04 |
| 2016-12-31 | $142.00K 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |